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Abstract
Background: Adolescence is a critical period for physical and psychological growth and development, and vitamin
and mineral requirements are correspondingly increased. Health and health behaviours correspond strongly from
adolescence to adulthood. Developing a preconception care package for adolescent and young women in
resource-limited settings could serve to empower them to make informed decisions about their nutrition, health,
and well-being, as well as function as a platform for the delivery of basic nutrition-related interventions to address
undernutrition.
Methods: In this population-based two-arm, cluster-randomized, controlled trial of life skills building education
(provided bi-monthly) and multiple micronutrient supplementation (provided twice-weekly; UNIMMAP composition)
, we aim to evaluate the effectiveness of the intervention on the prevention of anemia (hemoglobin concentration
< 12 g/dL) among adolescent and young women (15–24 years) in Matiari district, Pakistan compared to the
standard of care. Several secondary objectives related to nutrition (anthropometry [height, weight, middle upper
arm circumference (MUAC)], nutritional status [iron, vitamin A, vitamin D]); general health (morbidity, mortality); and
empowerment (age at marriage, completion of the 10th grade, use of personal hygienic materials during
menstruation) will also be assessed. Participants will be enrolled in the study for a maximum of 2 years.
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Discussion: Empowering adolescent and young women with the appropriate knowledge to make informed and
healthy decisions will be key to sustained behavioural change throughout the life-course. Although multiple
micronutrient deficiencies are known to exist among adolescent and young women in low-resource settings,
recommendations on preconception multiple micronutrient supplementation do not exist at this time. This study is
expected to offer insight into providing an intervention that includes both education and supplements to non-
pregnant adolescent and young women for a prolonged duration of time within the existing public health
programmatic context.
Trial registration: This study is part of the Matiari emPowerment and Preconception Supplementation (MaPPS) Trial.
The MaPPS Trial was registered retrospectively on clinicaltrials.gov (Identifier: NCT03287882) on September 19, 2017.
Keywords: Adolescence, Young adult, Nutrition, Micronutrients, Education, Preconception, Anemia, Empowerment
Plain English summary
In low- and middle-income countries many adolescent
and young women do not consume enough healthy and
nutrient-rich foods to meet their daily needs. Data show
that adolescent and young women in these places are
also more likely to become pregnant. If a woman is
undernourished when she becomes pregnant, it can have
a negative effect on her health, pregnancy, and infant. One
way to improve adolescent and young women’s health be-
fore they become pregnant is to provide a program that
aims to help them make healthy decisions and improve
their nutrition. This is often called preconception care. In
this study in rural Pakistan, we have designed a
culturally-appropriate preconception care package that in-
cludes life skills building education, to help study partici-
pants make better decisions about their health and educate
them about their rights, and multiple micronutrient supple-
ments, since they have limited access to foods with the
micronutrients that they need. Study participants (15–
24 years) are enrolled for 2 years, and we will assess several
factors about their nutrition, health, and well-being over
this time. The main effect we aim to determine is how
many participants have anemia among those who receive
the preconception care package compared to those who do
not receive it. Ultimately, we hope that what we learn in
this study will lead us to make recommendations about pol-
icies around preconception care for adolescent and young
women so that they can live healthier lives and make
healthier decisions.
Background
Within the Sustainable Development Goals, promoting
strategies to ensure the survival, health, and well-being of
adolescent girls, women, and their offspring has been rec-
ognized as an essential component to ending poverty [1].
Adolescence, in particular, is considered a neglected yet
critical period for physical and psychological growth and
development, given the transition from childhood to repro-
ductive adulthood [2]. Pregnancies to adolescents are asso-
ciated with a higher risk of complications and maternal
and child mortality [3], and contribute to 23% of the bur-
den of disease arising from pregnancy and childbirth [4].
When an adolescent becomes pregnant in a resource-
limited setting, her access to education generally
stops as a result; yet, educating girls is very effective
in raising overall economic productivity, lowering in-
fant and maternal mortality, improving nutrition,
and promoting health [5]. Collectively, this makes deter-
mining interventions to improve health outcomes from
adolescence of public health importance [2].
Nutritional deficiencies are risk factors known to exist
from adolescence, and have important consequences for
future maternal and newborn health. During adolescence,
vitamin and mineral requirements are incrementally in-
creased to support one’s ongoing physical development and
the nutritional strain of menstruation [6]. Given the limited
intake of animal products, fruits, vegetables, and fortified
foods in low- and middle-income countries, undernutrition
can be widely prevalent [7]. Deficiencies in multiple micro-
nutrients (MMN) are of particular concern given their dir-
ect effects, such as iron deficiency anemia and iodine
deficiency disorders, and their indirect effects, like in-
creased risk of serious infectious disease [6]. The burden
of undernutrition and its downstream consequences could
be prevented throughout the life course by using appro-
priate nutrition-specific and nutrition-sensitive interven-
tions, such as MMN supplementation and the
empowerment of women to make informed decisions, re-
spectively [5].
Since health and health behaviours correspond strongly
from adolescence to adulthood, habits acquired during
adolescence could have significant implications later in life
[2]. As such, developing a preconception care package for
adolescent and young women could serve to empower
them to make informed decisions about their health and
well-being [8], and function as a platform for the delivery
of basic nutrition-related interventions to address under-
nutrition [9]. Incorporating a life skills building education
(LSBE) element will be important to sustainable and profi-
cient uptake in improving their own general health,
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pregnancy outcomes, and future health of their children
[8]. However, at this time there is limited understanding as
to what health information should be provided and how
within preconception care.
We hypothesize that the programmatic provision of
LSBE and MMN supplements to non-pregnant adoles-
cent and young women 15–24 years of age in a
population-based setting in rural Pakistan will improve
selected nutrition, health, and empowerment-related
outcomes compared to those who receive the standard
of care. For those who receive the intervention, we ex-
pect that there will be a decrease in the prevalence of
anemia. Conducting this trial within the context of the
existing public health setting will allow us to assess the
effectiveness of the intervention, and offer important
insight around how to achieve coverage in the trial
setting.
Methods
The Matiari emPowerment and Preconception Supplemen-
tation (MaPPS) Trial is a two-arm, cluster-randomized,
controlled trial of LSBE and MMN supplementation pro-
vided in a programmatic context to evaluate the impact on
pre-identified nutrition and health outcomes among adoles-
cent and young women, and their infants born within the
context of the trial. Depending on whether participants be-
come pregnant or not, there are three phases: preconcep-
tion (maximum 24 months in duration); pregnancy
(approximately 9 months in duration); and postpartum
(maximum 12 months in duration). A detailed trial proto-
col has been developed in accordance with the SPIRIT
guidelines [10] in a collaboration between the Aga Khan
University (AKU; Karachi, Pakistan) and the Hospital for
Sick Children (Toronto, Ontario, Canada). This paper ad-
dresses the methods for ongoing data collection during
the preconception phase of the trial among participants
who do not become pregnant, with the methods for the
parent trial detailing the pregnancy and postpartum
phases appearing elsewhere ([11] unpublished).
The first participant was enrolled on 30 June 2017; en-
rollment is expected to be ongoing until July 2018; and
planned data collection will continue until 2021.
Objectives
The primary aim of the preconception phase of the
MaPPS Trial is to evaluate the impact of LSBE (provided
bi-monthly) and supplementation with MMN (provided
twice-weekly) versus the standard of care (non-regulated
community-based health sessions and no supplements)
on anemia (hemoglobin concentration < 12 g/dL) after
2 years among non-pregnant adolescents 15–18.9 years
of age at enrolment. There are several secondary objec-
tives to further determine the effect of LSBE and MMN
supplementation compared to the standard of care.
These relate to nutrition (anthropometry [height, weight,
middle upper arm circumference (MUAC)], nutritional
status [iron, vitamin A, vitamin D]); general health (e.g.,
morbidity, mortality); and empowerment (age at mar-
riage, completion of the 10th grade, and use of personal
hygienic materials during menstruation).
Setting and participants
This trial will be conducted in rural settings within
Matiari district in Sindh province, Pakistan. Briefly, the
nutritional status of adolescent girls in Pakistan is poor,
with 51 and 20% experiencing anemia and iron defi-
ciency anemia, respectively [12]. An urban/rural divide
is suggested to impact adolescent nutritional status [13],
with adolescents living in rural settings having particu-
larly limited dietary diversity [14]. The intervention is
situated within Pakistan’s existing Lady Health Worker
(LHW) Programme. Each LHW is affiliated with a health
facility and visit the homes in her catchment area
monthly to carry out community support sessions and
disseminate health education messages [15]. LHW-led
community sessions have the potential to serve as an
important communication channel for adolescents, espe-
cially those out of school. However, the content of exist-
ing LHW educational materials primarily focuses on
priority groups, including children < 5 years, pregnant
women, and couples eligible for family planning [16]. Al-
though the LHW curriculum includes some material on
topics important to the health of adolescent girls (e.g.,
dietary practices, anemia), these materials are not widely
implemented and not included in community sessions
regularly. More detail about the trial setting is described
in the parent trial protocol publication ([11]
unpublished).
Eligibility criteria
As the MaPPS Trial is a population-based effectiveness
study of LSBE and MMN supplementation from precon-
ception, broad eligibility criteria for participation in the
preconception phase were established. These include
that the minimum age at enrolment is 15 years and the
maximum age is 23 years; adolescent and young women
must also report to be physically able to comply with the
trial intervention. Adolescent and young women are not
eligible to enrol if they are pregnant, participating in a
different nutrition trial, or intend to leave the study area.
They can be of any marital status. If a participant be-
comes pregnant, she proceeds to the pregnancy phase of
the MaPPS Trial, as detailed in the parent study publica-
tion ([11] unpublished).
The micronutrient status and dietary intake of a
sub-sample of adolescent participants 15–18.9 years of
age at enrolment will also be monitored within the
MaPPS Trial. Participants recruited to the dietary
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assessment subgroup must also be a part of the micro-
nutrient status subgroup.
Design and sample size
The MaPPS Trial is a two-arm, parallel, prospective,
cluster-randomized, controlled trial (Fig. 1). A
cluster-randomized design was chosen to prevent con-
tamination between the control and intervention arms
through supplement sharing. The unit of randomization is
previously defined and mapped health facility clusters. A
total of 26 clusters are available to be randomized (i.e., 13
clusters per arm), and more detail around randomization
and allocation concealment are found with the description
of the parent study (Baxter et al., unpublished). PASS 11
Software (NCSS, LLC., Kaysville, UT, USA) was used to
determine all sample size calculations.
To observe a 20% relative reduction in the prevalence
of anemia among non-pregnant adolescent participants
15–18.9 years at enrolment, a 50% baseline prevalence
of anemia [12] was assumed. With icc = 0.0256, k = 0.16,
accounting for 15% attrition, and probability of type I
and type II errors of 0.05 and 0.20, respectively, the
number anemic adolescents required per cluster was 66.
This equates to 858 anemic adolescents per arm. To
achieve this reduction in anemia, 1716 adolescents per
arm will be required (3432 total). Given the number of
adolescent and young women required to be powered to
see a reduction in the primary outcome of the parent
trial (low birth weight), we aim to enrol 12,712 partici-
pants 15–24 years per arm (25,424 total).
To monitor the micronutrient status of a subgroup of
participants 15–18.9 years of age at enrolment, the sam-
ple size calculated for the reduction in anemia preva-
lence will be used (i.e., 1716 adolescents per arm). Stata
software (StataCorp, College Station, TX, USA) has been
used to randomly select 132 adolescents 15–18.9 years
at enrolment from each cluster. Dietary intake will also
be assessed in 200 randomly selected micronutrient sta-
tus subgroup participants per arm (15 women per clus-
ter), to further form a dietary status subgroup.
Intervention and control
LSBE materials
In intervention clusters, enhanced LSBE materials have
been developed on topics important to the empower-
ment of adolescent and young women to complement
the existing LHW materials for use in community ses-
sions. These will be implemented bi-monthly and at-
tendance will be recorded. Three topic areas were
prioritized: (a) delaying early marriage; (b) practicing ap-
propriate personal and menstrual hygiene; and (c) the
importance of good nutrition to health. Approximately
20 min is intended to be spent on each topic at commu-
nity sessions. Integrated throughout the 3 topics are
messages related to continuing one’s education, mental
health (how to cope with stress, anxiety, and when you
are upset), gender norms and equality, decision-making,
advocacy, resiliency, participation, communication skills,
facing challenges, agency, conflict resolution, and the
prevention of violence.
Communication tools have been developed to assist the
LHWs in conducting the LSBE-based community ses-
sions. These were designed in coordination with Aahung,
a Karachi-based non-governmental organization that aims
to improve the sexual and reproductive health of girls
(www.aahung.org; Karachi, Pakistan). Communication
tools include a flipchart with 2 pictorials and discussion
prompts per topic for use in sessions; and a brief summary
pamphlet for distribution to participants. The flipcharts
are similar to existing LHW tools for leading community
sessions. A team of master trainers is trained on all LSBE
materials and appropriate communication techniques.
The master trainers provide comprehensive and inter-
active training for all intervention LHWs. Refresher
Fig. 1 Matiari emPowerment and Preconception Supplementation (MaPPS) Trial flow diagram for participants who do not become pregnant
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training will also be provided on an ongoing basis
throughout the duration of the trial.
Trial supplements and administration
The MMN supplements provided to participants in the
intervention arm of the MaPPS Trial are consistent with
the UNICEF/WHO/UNU international multiple micronu-
trient preparation (UNIMMAP), and have been procured
from the UNICEF Supply Catalogue (https://supply.unice-
f.org). Each tablet is 10 mm in diameter and includes vita-
min A: 800 μg RE; vitamin D: 5 μg; vitamin E: 10 mg; folic
acid: 400 μg; vitamin B1 (thiamine): 1.4 mg; vitamin B2
(riboflavin): 1.4 mg; vitamin B3 (niacin): 18 mg; vitamin
B12: 2.6 μg; vitamin B6: 1.9 mg; vitamin C: 70 mg; iron:
30 mg; zinc: 15 mg; iodine: 150 μg; copper: 2000 μg; selen-
ium 65 μg (Micronutrient Tabs, Pregnancy; Lomapharm,
Emmerthal, Germany). All MMN supplements are main-
tained and stored by the study manager in a locked study
office that is temperature controlled. MMN supplements
are provided to LHWs monthly by a study monitoring
team, which is unblinded to the allocation of the interven-
tion and not involved in data collection. Participants’ per-
sonal supply of MMN supplements are monitored and
replenished every month by their respective LHWs. Once
provided to participants, MMN supplements are stored in
marked, opaque containers labelled with the participant’s
ID and supplement batch number and expiry date.
Upon enrolment in the trial, intervention arm LHWs
will visit new participants within 1 month to provide
MMN supplements. Participants are asked to consume 1
MMN tablet 2 days/week. To make the incorporation
MMN supplementation into their routine easier, partici-
pants are requested to choose a consistent time on 2 days
in the week that are separate from each other (e.g., Mon-
day and Thursday, or Wednesday and Saturday) on which
to take 1 MMN tablet with a glass of water and a meal.
Each participant is provided with a 1 month supply of
MMN supplements, plus a spare week in case of unsched-
uled missed visits. As such, participants receive 10 MMN
tablets per month (4 weeks/month × 2 tablets/week + 2
extra tablets = 10 tablets total). If a participant does not
become pregnant within the context of the trial, she will
take the MMN supplements for up to 24 months (the
maximum duration of the preconception period).
Participants are instructed that the MMN supplements
are just for them and should be kept away from children.
They are asked to ensure that the lid of the supplement
bottle is tightly closed when not in use and stored away
from light and humidity. It is also explained that some
people experience mild side effects when they start tak-
ing the MMN supplements (e.g., nausea, vomiting, diar-
rhea, stomach pains), but that taking it with food should
make side effects less likely to happen. If they miss a
dose, participants are instructed to take 1 MMN tablet
the next time that they remember, but never to consume
more than 1 tablet/day. If a participant has any side ef-
fects, is concerned, or has questions, she is instructed to
contact her LHW and not study personnel since study
personnel are blinded to whether participants are in the
control or intervention arm. Participants are also asked
not to take non-trial administered supplements while
they are enrolled in the trial.
Enrolment and consent
Adolescent and young women in LHW-covered areas in
Matiari district were identified in a household listing ex-
ercise. Provisionally eligible participants will be invited
to participate in MaPPS Trial with their family members
and/or husbands present. Data collectors will explain the
purpose and voluntary nature of the trial; participation
components; and potential benefits and harms prior to
obtaining written informed consent. If participants are <
16 years of age, assent will also be obtained as necessary.
It is anticipated that enrolment will take at least 1 year.
Visit schedule
All visits with study participants will occur at their
homes (Table 1). Upon enrolment in the trial, a ques-
tionnaire designed to collect information on demograph-
ics; socioeconomic status (SES); reproductive health and
history; life skills, empowerment, and social determi-
nants of health (SDH)-related factors (Table 2); supple-
mentation practices; and access to LHWs will be
administered. This questionnaire has been adapted from
the existing demographic health survey for Pakistan and
several standardized assessment tools. All participants
will also undergo anthropometric (height, weight,
MUAC) and hemoglobin concentration measurement.
After 12 months of enrolment in the preconception
phase, all participants’ anthropometric measures (height,
weight, MUAC) will be reassessed. After 24 months, all
participants will be asked to complete a modified version of
the baseline questionnaire for ongoing assessment of life
skills, empowerment, and SDH-related factors; and
undergo repeat anthropometric (height, weight, MUAC)
and hemoglobin concentration measurements. Upon trial
completion or withdrawal, participants will be asked to
complete an exit questionnaire designed to assess their per-
ception of their own health and satisfaction with trial
participation.
Additional measures will be collected from partici-
pants in the micronutrient status subgroup, including a
5 mL blood draw at enrolment and after 24 months; re-
peat anthropometric assessment (height, weight, MUAC)
after 6 months; and a modified version of the baseline
questionnaire for ongoing assessment of life skills and
empowerment at 12 months. Participants in the dietary
status subgroup will complete 3 dietary assessments
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(24-h food recall, weekly food group consumption sur-
vey) over the 3 weeks following enrolment in the trial.
Dietary assessment days will be non-consecutive and un-
announced, and include 2 weekdays and 1 weekend day.
LHW visits
Because LHWs are required to visit households in their
catchment areas monthly, these visits will serve to moni-
tor menses, new marriages, and suspected pregnancies
throughout the duration of the trial, in addition to their
mandated function [15]. All trial-administered supple-
ment provision and consumption will also be recorded
at these visits.
Adherence, morbidity, and morbidity monitoring
There will also be ongoing participant monitoring for
the duration of the trial (Table 3). All participants will
be visited by an independent surveillance team to collect
morbidity and self-reported adherence data every
3 months. These visits will also allow for the observance
and collection of data on non-trial administered nutri-
tional supplement consumption.
Data collection
Data collection tools have been customized for each type
of visit, and data is collected orally given the low literacy
rates in the trial population. Trained study personnel
will collect all trial outcome data using questionnaires,
anthropometric measurements, point-of-care tests, and
dietary recall methods. Standardized operating proce-
dures have been developed for all measures in an effort
to make data collection practices consistent. Extensive
training sessions will be provided to study personnel,
employing classroom-based lectures, videos, hands-on
practice, and mock interviews.
Questionnaires
For data collector-conducted visits with participants,
tablets (Samsung Galaxy Tab. A T285; Samsung,
Vietnam) will be used to collect questionnaire data. The
tablets run a custom-made data collection application,
which includes built-in logic and range checks. LHW
monitoring visits will use paper-based questionnaires
given the large number of LHWs involved in the trial.
Dietary assessments will also be paper-based.
Anthropometric measurements
To assess adolescent and young women’s anthropomet-
rics, height will be measured using a stadiometer (seca
213; seca, Hamburg, Germany); weight using a digital
floor scale (seca 813); and MUAC using a measuring
tape (seca 201). All measurements will be conducted in
Table 1 Preconception phase data collection and measurement
activities
Activity Month of participation
0 6 12 24
Consent X
Demographics and SES X M X
Reproductive health and history X
Life skills, empowerment, and SDH X M X
Anthropometry X M X X
Hemoglobin X M X
Serum ferritin M M M
Hepcidin M M M
Transferrin receptor M M M
Infection indicators (CRP, AGP) M M M
Vitamin A M M M
Vitamin D M M M
Household food insecurity X M X
Food group consumption survey (1 week) D
24-h recall D
X: all participants; M micronutrient status subgroup participants only; D dietary
status subgroup participants only
Table 2 Factors relating to life skills, empowerment, and SDH captured within trial questionnaires
Domains Includes information pertaining to Evaluation tool
Nutrition Household food insecurity Household Food Insecurity Access Scale [17]
Health Eating habits Health Behaviour in School-aged Children [18]
Body image
Physical activity
Perception of support Family, peer, and school Multidimensional Scale of Perceived Social Support [19]
Decision making Family, food, healthcare, and daily needs Pakistan Demographic Health Survey [20]
Psychosocial health Self-efficacy Generalized self-efficacy scale [21]
Stress Perceived stress scale [22]
Mental health (depression, anxiety, and stress) Depression, Anxiety, and Stress Scale-21 [23]
Violence Intimate partner violence Conflict Tactics Scale [24]
Exposure to violence Pakistan Demographic Health Survey [20]
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duplicate by 2 data collectors. In the case that 2 mea-
surements exceed the pre-set allowable differences
(height: < 1.0 cm; weight: < 0.5 kg; MUAC: < 0.5 cm), a
third measurement will be obtained. The average (mean)
of acceptable paired measures will be used in analysis.
Point-of-care hemoglobin assessment
To assess hemoglobin concentration, the HemoCue® Hb
301 System (HemoCue; Ängelholm, Sweden) will be
used from blood collected via finger prick.
24-h dietary recall
Among participants enrolled in the dietary assessment
subgroup, usual dietary intake will be assessed using an
interactive 24-h recall method [25] administered by
trained food recall data collectors. Consumed food por-
tions will be estimated and identified using a locally de-
veloped food kit and food item reference manual [26].
Blood specimen collection and laboratory analyses
Trained phlebotomists (blinded to cluster allocation) will
conduct all blood specimen collection using standard
sampling procedures developed by the AKU Nutrition Re-
search Lab. At each sampling time point, 5 mL of venous
blood will be collected and stored in trace element-free
vacutainer tubes (royal blue top; Greiner Bio-One, Mon-
roe, NC, USA). Two drops of whole blood are immedi-
ately taken from the collection tube to assess hemoglobin
concentration using the HemoCue® Hb 301 System point
of care test. Samples will be further assessed for markers
of nutritional status (iron [ferritin, transferrin receptor,
hepcidin], vitamin A [retinol], and vitamin D [25(OH)D])
and inflammation (c-reactive protein, alpha-1-acid glyco-
protein). More details on blood specimen collection and
assays can be found within the description of the parent
trial (Baxter et al., unpublished).
Data management
Data collection tablets are collected from study
personnel on a daily basis so that questionnaire data
can be uploaded to the AKU data management unit.
Paper-based questionnaire forms are visually checked
by field site supervisors for completeness before being
sent to the AKU data management unit on a weekly
basis for entry into a database. Double data entry is
used to reduce data entry errors. All collected data is
kept under lock and key, and anonymized through
the use of nine-digit participant identification codes.
Data entered into the database is password protected.
Outcome measures
To assess the prevalence of anemia, the primary out-
come measures is hemoglobin concentration < 12 g/dL.
There are many additional secondary outcomes within
the trial related to health, nutrition, and empowerment
that will be also assessed (see Additional file 1).
Statistical analysis
For the primary outcome, the prevalence of anemia will
be compared by intervention arm, irrespective of precon-
ception supplementation duration or adherence (inten-
tion-to-treat). The per-protocol analysis will consider
those women who complied with the recommend MMN
supplementation frequency. Because the prevalence of
anemia is high in the trial population, an individual-level
analysis using generalized estimating equations (GEE) will
be employed to determine the estimate of the population
average. Clustering will be accounted for within the GEE
analysis. There are several potential determinants which
will be considered as covariates, such as age, parity, adher-
ence, and SES. Relevant information will be collected at
enrolment and throughout follow-up. Summary estimates
(e.g., means, proportions, counts) will be reported with
95% confidence intervals. Dichotomous outcomes will be
compared using risk ratios with 95% confidence intervals,
and the difference in continuous variables will be deter-
mined by comparing means. P values less than 0.05 will
be considered statistically significant. Statistical analyses
will be conducted using Stata software. The plan for the
analysis of secondary objectives and outcome measures
will be presented elsewhere.
Table 3 Monitoring data collection activities ongoing throughout the trial
Measurement Monthly (LHW) Quarterly (Monitoring Team)
Adherence by pill counta i
Adherence by self-reported frequencyb i
Side effects X
Supplement acceptability i
Morbidity X
Mortality X
X: all participants; i: intervention group only
aAdherence by pill count defined as number of tablets apparently consumed/number of possible supplements consumed given the number of days enrolled in
the study
bAdherence options by self-report during preconception include twice weekly, intermittently, or not at all
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Discussion
In this trial, we aim to assess the effectiveness of providing
LSBE and MMN supplementation to non-pregnant ado-
lescent and young women in rural Pakistan from precon-
ception, and compare this intervention with the standard
of care on anemia prevalence and other secondary health
outcomes. The intervention will be implemented within
the existing public health system, which is anticipated to
lend to the interpretability of the trial findings and offer
important insight around how to achieve coverage within
the existing public health program context. This trial is
distinctive in that it recruits both married and unmarried
adolescent and young women, regardless of their intent to
become pregnant, and collects measures on several do-
mains of health and nutrition throughout participation.
The existing WHO guidelines on iron supplementa-
tion for non-pregnant adolescent and menstruating
women can be confusing, particularly with respect to dos-
ing frequency (weekly versus daily) and duration [27, 28].
At this time, we know of no guidelines that address pre-
conception MMN supplementation. For adolescents, in
particular, preconception care that includes MMN
supplementation could be of benefit given that they are
still developing and anemia can be caused by multiple dif-
ferent micronutrient deficiencies beyond iron [29, 30]. In-
cluding a culturally-tailored educational piece aimed
at empowering the ability of participants to make in-
formed decisions about their health, well-being, and
nutrition will be key to sustained behavioural change
throughout the life-course. Similarly, guidelines on
pre-pregnancy nutritional counselling specific to ado-
lescents are not known to exist, even though attend-
ing to adolescents’ nutritional needs will be important
in addressing intergenerational malnutrition, chronic dis-
ease, and poverty [31]. Appropriate preconception care
could allow that adolescents enter reproductive adulthood
with improved health and nutrition status prior to
conception.
Overall, the MaPPS Trial is expected to offer
insight into providing an intervention that includes
both LSBE and MMN supplementation to adolescent and
young women from preconception and for a prolonged
duration of time. We anticipate that there would be future
follow up of the adolescent and young women in this co-
hort, so as to understand their long-term reproductive
and empowerment outcomes, as well as development and
disease outcomes. We also intend to investigate the
cost-effectiveness of the provision of the described
intervention.
Trial status
As of May 2018, participants are still being enrolled to
the trial.
Additional file
Additional file 1 Additional tables detailing secondary outcome
measures and cut-points. The additional file includes 3 tables detailing
secondary nutritional status, anthropometric, and empowerment out-
come measures for participants. (DOCX 23 kb)
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